Published in J Biomed Biotechnol on August 25, 2010
Selective HPLC method development for soy phosphatidylcholine Fatty acids and its mass spectrometry. Indian J Pharm Sci (2013) 0.75
Structural Elucidation and Molecular Docking of a Novel Antibiotic Compound from Cyanobacterium Nostoc sp. MGL001. Front Microbiol (2016) 0.75
Inositol trisphosphate and calcium signalling. Nature (1993) 25.57
Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci U S A (1997) 4.61
The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta (1984) 3.58
Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta (1994) 3.42
Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res (2005) 2.11
Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res (2006) 1.88
Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Anal Chem (2007) 1.81
Liquid chromatography/mass spectrometry of phospholipids using electrospray ionization. Anal Chem (1994) 1.61
Sphingomyelin and derivatives as cellular signals. Prog Lipid Res (1991) 1.47
Analysis of intact phosphoinositides in biological samples. J Lipid Res (2006) 1.41
Validation of a one-step extraction/methylation method for determination of fatty acids and cholesterol in marine tissues. J Chromatogr A (2005) 1.34
NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes. J Lipid Res (2007) 1.30
Microanalysis of complex tissue lipids by high-performance thin-layer chromatography. Anal Biochem (1985) 1.17
Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients. Int J Cancer (1997) 1.16
Regulation of the epithelial sodium channel by phosphatidylinositides: experiments, implications, and speculations. Pflugers Arch (2007) 1.10
Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J Lipid Res (2007) 1.04
Separation of phospholipids by high-performance liquid chromatography: all major classes, including ethanolamine and choline plasmalogens, and most minor classes, including lysophosphatidylethanolamine. J Chromatogr (1986) 1.03
Thin-layer chromatographic procedures for lipid separation. J Chromatogr B Biomed Appl (1995) 1.02
Improved high-performance liquid chromatographic method for the separation and quantification of lipid classes: application to fish lipids. J Chromatogr B Biomed Sci Appl (1997) 1.00
Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis. NMR Biomed (2000) 0.97
Lipids isolated from bone induce the migration of human breast cancer cells. J Lipid Res (2006) 0.96
Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. Breast Cancer Res Treat (1992) 0.95
Molecular species analysis of phospholipids. J Chromatogr B Biomed Sci Appl (1997) 0.94
31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma. NMR Biomed (2002) 0.93
Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol (1998) 0.93
An introduction to the potential of 1H-, 31P- and 13C-NMR-spectroscopy. Anticancer Res (1996) 0.92
Aminophospholipid molecular species asymmetry in the human erythrocyte plasma membrane. Biochim Biophys Acta (1991) 0.91
General strategies in chromatographic analysis of lipids. J Chromatogr B Biomed Appl (1995) 0.90
Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy. NMR Biomed (2005) 0.88
Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuronal differentiation. J Lipid Res (2006) 0.88
Application of high resolution 31P NMR spectroscopy to the characterization of the phospholipid composition of tissues and body fluids - a methodological review. Med Sci Monit (2002) 0.87
ESI-MS quantitation of increased sphingomyelin in Niemann-Pick disease type B HDL. J Lipid Res (2005) 0.87
Changes of intracellular calcium, fatty acids and phospholipids during miltefosine-induced apoptosis monitored by fluorescence- and 13C NMR-spectroscopy. Anticancer Res (2000) 0.86
Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega-6 fatty acids. Cancer Lett (1998) 0.86
The presence of oxidized phosphatidylserine on Fas-mediated apoptotic cell surface. Biochim Biophys Acta (2005) 0.85
Analysis of phospholipid molecular species in brain by (31)P NMR spectroscopy. Magn Reson Med (2000) 0.84
Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK. J Lipid Res (2005) 0.84
Combined extraction techniques of tumour cells and lipid/phospholipid assignment by two dimensional NMR spectroscopy. Anticancer Res (1996) 0.80
Malignant breast tumor phospholipid profiles using (31)P magnetic resonance. Cancer Lett (2002) 0.79
Characterization of sphingomyelins in lipid extracts using a HPLC-MS-Offline-NMR method. Anal Chem (2007) 0.79
Detection of phosphatidylcholine oxidation products in rat heart using quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.77
Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol (2006) 21.58
Effects of hypothermia on brain glucose metabolism in acute liver failure: a H/C-nuclear magnetic resonance study. Gastroenterology (2003) 1.60
Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy. Mov Disord (2012) 1.46
Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview. J Chromatogr A (2005) 1.43
Recurrent metabolic acidosis in a dialysis patient. Kidney Int (2010) 1.40
Spatial segmentation of imaging mass spectrometry data with edge-preserving image denoising and clustering. J Proteome Res (2010) 1.20
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders. Ann Neurol (2012) 1.14
Toward quantitative short-echo-time in vivo proton MR spectroscopy without water suppression. Magn Reson Med (2006) 1.13
Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed (2003) 1.12
Development and validation of an assay for the quantification of 11 nucleotides using LC/LC-electrospray ionization-MS. Anal Biochem (2007) 1.09
Collagen I fiber density increases in lymph node positive breast cancers: pilot study. J Biomed Opt (2012) 1.08
New method for the simultaneous detection of metabolites and water in localized in vivo 1H nuclear magnetic resonance spectroscopy. Magn Reson Med (2005) 1.08
Regulation of glial metabolism studied by 13C-NMR. NMR Biomed (2003) 1.07
MALDI-TOF mass spectrometry-based SNP genotyping. Pharmacogenomics (2002) 1.07
Diffusion in compartmental systems. I. A comparison of an analytical model with simulations. Magn Reson Med (2003) 1.07
Mass spectrometry-based clinical proteomics. Pharmacogenomics (2003) 1.06
Energy metabolism in astrocytes and neurons treated with manganese: relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis. J Cereb Blood Flow Metab (2003) 1.06
Exploring three-dimensional matrix-assisted laser desorption/ionization imaging mass spectrometry data: three-dimensional spatial segmentation of mouse kidney. Anal Chem (2012) 1.04
Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells. Br J Pharmacol (2009) 1.04
Biomarker discovery in MALDI-TOF serum protein profiles using discrete wavelet transformation. Bioinformatics (2009) 1.03
HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategy. Proteomics (2006) 1.02
Diffusion in compartmental systems. II. Diffusion-weighted measurements of rat brain tissue in vivo and postmortem at very large b-values. Magn Reson Med (2003) 1.01
A continuous-flow, high-throughput, high-pressure parahydrogen converter for hyperpolarization in a clinical setting. NMR Biomed (2012) 1.00
Association of DJ-1/PTEN/AKT- and ASK1/p38-mediated cell signalling with ischaemic cardiomyopathy. Cardiovasc Res (2012) 0.99
Subfield-specific loss of hippocampal N-acetyl aspartate in temporal lobe epilepsy. Epilepsia (2007) 0.96
Interpretation of mass spectrometry data for high-throughput proteomics. Anal Bioanal Chem (2003) 0.95
Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation. Nephron Exp Nephrol (2009) 0.94
Brain energy metabolism in a sub-acute rat model of manganese neurotoxicity: an ex vivo nuclear magnetic resonance study using [1-13C]glucose. Neurotoxicology (2004) 0.93
Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors. Br J Pharmacol (2004) 0.93
Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. Hepatology (2003) 0.93
Automated reprocessing pipeline for searching heterogeneous mass spectrometric data of the HUPO Brain Proteome Project pilot phase. Proteomics (2006) 0.91
Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function. Chem Res Toxicol (2009) 0.90
Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study. J Proteome Res (2010) 0.90
Separation of phospholipid classes by hydrophilic interaction chromatography detected by electrospray ionization mass spectrometry. J Chromatogr A (2010) 0.90
On the importance of mathematical methods for analysis of MALDI-imaging mass spectrometry data. J Integr Bioinform (2012) 0.89
New analysis workflow for MALDI imaging mass spectrometry: application to the discovery and identification of potential markers of childhood absence epilepsy. J Proteome Res (2012) 0.87
Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism. Chem Res Toxicol (2010) 0.87
Experimental method to eliminate frequency modulation sidebands in localized in vivo 1H MR spectra acquired without water suppression. Magn Reson Med (2004) 0.86
Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurosci (2007) 0.85
MRI-compatible pipeline for three-dimensional MALDI imaging mass spectrometry using PAXgene fixation. J Proteomics (2013) 0.85
Na(+)/H(+) exchange subtype 1 inhibition during extracellular acidification and hypoxia in glioma cells. J Neurochem (2002) 0.85
Fast U-FLARE-based correlation-peak imaging with complete effective homonuclear decoupling. Magn Reson Med (2003) 0.83
Fast three-dimensional 1H MR spectroscopic imaging at 7 Tesla using "spectroscopic missing pulse--SSFP". Magn Reson Med (2008) 0.83
Glial metabolism of valine. Neurochem Res (2009) 0.83
Selective alterations of brain osmolytes in acute liver failure: protective effect of mild hypothermia. Brain Res (2004) 0.83
Comparison of the effects of cyclosporin a on the metabolism of perfused rat brain slices during normoxia and hypoxia. J Cereb Blood Flow Metab (2002) 0.82
A metabonomic and proteomic analysis of changes in IMCD3 cells chronically adapted to hypertonicity. Nephron Physiol (2008) 0.82
Nmr spectroscopic analysis of regional brain energy metabolism in manganese neurotoxicity. Glia (2007) 0.82
Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose. Br J Clin Pharmacol (2010) 0.82
Even-electron ions: a systematic study of the neutral species lost in the dissociation of quasi-molecular ions. J Mass Spectrom (2007) 0.82
Protein Information and Knowledge Extractor: Discovering biological information from proteomics data. Proteomics (2010) 0.82
Sustained hydrogen peroxide stress decreases lactate production by cultured astrocytes. J Neurosci Res (2009) 0.82
Fast 3D 1H spectroscopic imaging at 3 Tesla using spectroscopic missing-pulse SSFP with 3D spatial preselection. Magn Reson Med (2007) 0.80
Fast 1H spectroscopic imaging using steady state free precession and spectral-spatial RF pulses. MAGMA (2006) 0.80
On the spin order transfer from parahydrogen to another nucleus. J Magn Reson (2012) 0.80
MALDI imaging mass spectrometry: discrimination of pathophysiological regions in traumatized skeletal muscle by characteristic peptide signatures. Proteomics (2014) 0.80
Gaining knowledge from previously unexplained spectra-application of the PTM-Explorer software to detect PTM in HUPO BPP MS/MS data. Proteomics (2006) 0.80
Characterization of sphingomyelins in lipid extracts using a HPLC-MS-Offline-NMR method. Anal Chem (2007) 0.79
Metabolism of [U-(13)C]aspartate by astroglial cultures: nuclear magnetic resonance analysis of the culture media. Neurochem Res (2010) 0.79
Fast proton spectroscopic imaging with high signal-to-noise ratio: spectroscopic RARE. Magn Reson Med (2002) 0.79
Effects of zero-filling and apodization on spectral integrals in discrete Fourier-transform spectroscopy of noisy data. J Magn Reson (2006) 0.79
Glial metabolism of isoleucine. Neurochem Res (2008) 0.78
Application of slicing of one-dimensional gels with subsequent slice-by-slice mass spectrometry for the proteomic profiling of human liver cytochromes P450. J Proteome Res (2010) 0.78
The feasibility of MS and advanced data processing for monitoring Schistosoma mansoni infection. Proteomics Clin Appl (2010) 0.78
Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism. Neurotoxicology (2010) 0.78
Contribution of extracellular glutamine as an anaplerotic substrate to neuronal metabolism: a re-evaluation by multinuclear NMR spectroscopy in primary cultured neurons. Neurochem Res (2005) 0.78
RF refocused echoes of J-coupled spin systems: effects on RARE-based spectroscopic imaging. Magn Reson Med (2007) 0.78
PRESS-based proton single-voxel spectroscopy and spectroscopic imaging with very short echo times using asymmetric RF pulses. MAGMA (2003) 0.77
Quantitative statistical analysis of standard and human blood proteins from liquid chromatography, electrospray ionization, and tandem mass spectrometry. J Proteome Res (2012) 0.77
Metabolism of [U-(13)C]leucine in cultured astroglial cells. Neurochem Res (2004) 0.77
Ammonia toxicity under hyponatremic conditions in astrocytes: de novo synthesis of amino acids for the osmoregulatory response. Neurochem Int (2005) 0.76
Fast three-dimensional proton spectroscopic imaging of the human brain at 3 T by combining spectroscopic missing pulse steady-state free precession and echo planar spectroscopic imaging. Magn Reson Med (2011) 0.76
Fast proton spectroscopic imaging using steady-state free precession methods. Magn Reson Med (2003) 0.75
Fast 3D echo planar SSFP-based 1H spectroscopic imaging: demonstration on the rat brain in vivo. Magn Reson Imaging (2006) 0.75
Towards data management of the HUPO Human Brain Proteome Project pilot phase. Proteomics (2004) 0.75
Hyphenated tools for phospholipidomics. J Biomol Tech (2008) 0.75
5th HUPO BPP Bioinformatics Meeting at the European Bioinformatics Institute in Hinxton, UK--Setting the analysis frame. Proteomics (2005) 0.75
Getting a grip on proteomics data - Proteomics Data Collection (ProDaC). Proteomics (2009) 0.75